retatrutide safety retatrutide clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide parkinson's clinical trial Reta

Though GLP-1RAs are increasingly being prescribed for off-label uses, more than nine in 10 of the physicians surveyed across all specialties have prescribed a GLP-1RA medication for weight loss

Central nervous system effects remain theoretical

[DOI] [PubMed] [Google Scholar] Peyot ML, Gray JP, Lamontagne J, Smith PJ, Holz GG, Madiraju SR, Prentki M, Heart E

The biological mechanism explains why lower-dose strategies are plausible, but dose size determines how strong the effect becomes

For instance, if patients present with symptoms such as early hunger or lack of satiety then a GLP-1RA may be appropriate compared with other available treatments that work solely by suppressing appetite or inhibiting fat absorption [23]

Consult our professionals at The WellSpa to create a personalized plan that fits your lifestyle